Michigan Translational Research And Commercialization Program
Supports MTRAC, funding translational research and commercialization pathways across Michigan universities, hospitals, and nonprofits.
MTRAC (Michigan Translational Research and Commercialization Program) is a MEDC-backed programme created in 2012 and expanded statewide in 2016. It directs translational research toward commercialization through five named innovation hubs: MSU Agri Bio, U-M Life Sciences, U-M Advanced Transportation, Michigan Tech Advanced Materials, and Wayne State Advanced Computing. The programme is rolling, Michigan-centered, and directed at institutions rather than direct company applicants. Eligible entities are universities, nonprofit research centers, and hospital systems in Michigan. Program documentation notes indicate the full operational details are in a PDF that is not available in this extraction, so cycle and award-scale specifics are limited in this summary. The model is best matched to institutions with formal commercialization pathways and hub-specific domain focus.
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.